IRVINE, Calif., Nov. 16, 2020 /PRNewswire/ -- Allergan
Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its
second annual BOTOX® Cosmetic Day on Wednesday, November 18, 2020. The event is
dedicated to celebrating the iconic treatment that helped create
the aesthetics industry and recognizing the loyal community of
patients and healthcare providers who have helped make this brand
what it is today. In addition, this is a day for both new and loyal
BOTOX® Cosmetic users to put themselves first with an
exclusive one-day-only offer available while supplies last
exclusively through AllēSM, the new loyalty platform
from Allergan Aesthetics.
BOTOX® Cosmetic Day is a very special holiday for
Allergan Aesthetics. The brand is dedicated to encouraging patients
and providers to do something for themselves especially ahead of
the holiday season.
"BOTOX® Cosmetic Day is also all about our loyal
healthcare providers. From partnering with them on product
formulations and clinical trials, to patient education and
treatment, our providers are at the core of everything that goes
into our products," says Carrie
Strom, Senior Vice President, AbbVie, and President, Global
Allergan Aesthetics. "There are ten million people considering a
facial injectable treatment in the next year, and BOTOX®
Cosmetic Day serves as an opportunity to connect these consumers
with healthcare providers in their area.1 We are
incredibly grateful for the knowledge and diligent work providers
contribute to our brands and the entire aesthetic category. We
encourage everyone to thank their providers, even if it is a
virtual celebration this year."
On November 18, consumers who are
new or existing members of AllēSM, Allergan Aesthetics'
new loyalty program, can participate in the exclusive offer which
will be announced at 9 am Pacific
Time on BOTOX® Cosmetic Day at
www.BOTOXCosmeticDay.Alle.com.
"BOTOX® Cosmetic Day is a testament to the impact
this brand has had on the aesthetic community," said Dr.
Jean Carruthers, MD, FRCSC,
FRC(Ophth). "In the past three decades, I've personally been on the
front lines of continued research for this molecule and have
witnessed the exponential increase in interest in this treatment,
both among patients and the medical community
worldwide.2 With the largest scientific and medical
bibliography, BOTOX® Cosmetic is the most widely studied
treatment of its kind.3 I will continue to rely on
BOTOX® Cosmetic in my practice for its safety, efficacy
and predictable results when treating my patients. I am honored to
stand with my peers in the medical community and friends
at Allergan Aesthetics to celebrate the one and only
BOTOX® Cosmetic."
BOTOX® Cosmetic is the first and only neurotoxin
FDA-approved to temporarily improve the appearance of moderate to
severe forehead lines, crow's feet lines, and glabellar lines in
adults, and physicians have relied on it for more than 18
years.4 Recognized by National Day Archives as an
official holiday on the National Day Registry™, BOTOX®
Cosmetic Day is held annually on the third Wednesday in November.
Visit www.BOTOXCosmeticDay.Alle.com for more information and to
purchase a gift card. Limited time offer. Terms and conditions
apply.
BOTOX® (onabotulinumtoxinA) Important
Information
IMPORTANT SAFETY INFORMATION
BOTOX® and
BOTOX® Cosmetic may cause serious side effects that can be
life threatening. Get medical help right away if you have any of
these problems any time (hours to weeks) after injection of
BOTOX® or BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to
weakening of associated muscles, can be severe and result in loss
of life. You are at the highest risk if these problems are
pre-existing before injection. Swallowing problems may last for
several months
- Spread of toxin effects. The effect of botulinum toxin
may affect areas away from the injection site and cause serious
symptoms including: loss of strength and all-over muscle weakness,
double vision, blurred vision and drooping eyelids, hoarseness or
change or loss of voice, trouble saying words clearly, loss of
bladder control, trouble breathing, and trouble swallowing
There has not been a confirmed serious case of spread of toxin
effect away from the injection site when BOTOX® has been used at
the recommended dose to treat Chronic Migraine, severe underarm
sweating, Blepharospasm, Strabismus, or when BOTOX® Cosmetic has
been used at the recommended dose to treat frown lines, crow's feet
lines, and/or forehead lines.
Indications
BOTOX® is a prescription medicine that is
injected into muscles and used:
- To treat overactive bladder symptoms such as a strong need to
urinate with leaking or wetting accidents (urge urinary
incontinence), a strong need to urinate right away (urgency), and
urinating often (frequency) in adults 18 years and older when
another type of medicine (anticholinergic) does not work well
enough or cannot be taken
- To treat leakage of urine (incontinence) in adults 18 years and
older with overactive bladder caused by a neurologic disease who
still have leakage or cannot tolerate the side effects after trying
an anticholinergic medication
- To prevent headaches in adults with Chronic Migraine who have
15 or more days each month with headache lasting 4 or more hours
each day in people 18 years or older
- To treat increased muscle stiffness in people 2 years of age
and older with spasticity
- To treat the abnormal head position and neck pain that happens
with Cervical Dystonia (CD) in people 16 years and older
- To treat certain types of eye muscle problems (Strabismus) or
abnormal spasm of the eyelids (Blepharospasm) in people 12 years
and older
BOTOX® is also injected into the skin to treat the symptoms of
severe underarm sweating (severe primary axillary hyperhidrosis)
when medicines used on the skin (topical) do not work well enough
in people 18 years and older.
BOTOX® Cosmetic is a prescription medicine that is injected into
muscles and used to temporarily improve the look of moderate to
severe forehead lines, crow's feet lines, and frown lines between
the eyebrows in adults.
It is not known whether BOTOX® and BOTOX® Cosmetic are safe or
effective to prevent headaches in patients with migraine who have
14 or fewer headache days each month (episodic migraine).
BOTOX® has not been shown to help people perform task-specific
functions with their upper limbs or increase movement in joints
that are permanently fixed in position by stiff muscles.
It is not known whether BOTOX® and BOTOX® Cosmetic are safe or
effective for severe sweating anywhere other than your armpits.
It is not known if BOTOX® Cosmetic is safe or effective for use
more than 1 time every 3 months.
IMPORTANT SAFETY INFORMATION (continued)
BOTOX® and
BOTOX® Cosmetic may cause loss of strength or general muscle
weakness, vision problems, or dizziness within hours to weeks of
taking BOTOX® or BOTOX® Cosmetic. If this happens, do not drive
a car, operate machinery, or do other dangerous activities.
Do not receive BOTOX® or BOTOX® Cosmetic if
you: are allergic to any of its ingredients (see Medication
Guide for ingredients); had an allergic reaction to any other
botulinum toxin product such as Myobloc®
(rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or
Xeomin® (incobotulinumtoxinA); have a skin infection at the
planned injection site.
Do not receive BOTOX® for the treatment of urinary
incontinence if you: have a urinary tract infection (UTI) or
cannot empty your bladder on your own and are not routinely
catheterizing. Due to the risk of urinary retention (not being able
to empty the bladder), only patients who are willing and able to
initiate catheterization post treatment, if required, should be
considered for treatment.
Patients treated for overactive bladder:
In clinical
trials, 36 of the 552 patients had to self-catheterize for urinary
retention following treatment with BOTOX® compared to 2 of the 542
treated with placebo. The median duration of postinjection
catheterization for these patients treated with BOTOX® 100 Units (n
= 36) was 63 days (minimum 1 day to maximum 214 days) as compared
to a median duration of 11 days (minimum 3 days to maximum 18 days)
for patients receiving placebo (n = 2). Patients with diabetes
mellitus treated with BOTOX® were more likely to develop urinary
retention than nondiabetics.
Patients treated for overactive bladder due to neurologic
disease:
In clinical trials, 30.6% of patients (33/108) who
were not using clean intermittent catheterization (CIC) prior to
injection, required catheterization for urinary retention following
treatment with BOTOX® 200 Units as compared to 6.7% of patients
(7/104) treated with placebo. The median duration of postinjection
catheterization for these patients treated with BOTOX® 200 Units (n
= 33) was 289 days (minimum 1 day to maximum 530 days) as compared
to a median duration of 358 days (minimum 2 days to maximum 379
days) for patients receiving placebo (n = 7). Among patients not
using CIC at baseline, those with MS were more likely to require
CIC post injection than those with SCI.
The dose of BOTOX® and BOTOX® Cosmetic is not
the same as, or comparable to, any other botulinum toxin
product.
Serious and/or immediate allergic reactions have been
reported, including itching, rash, red itchy welts, wheezing,
asthma symptoms, dizziness, or feeling faint. Get medical help
right away if you experience symptoms; further injection of BOTOX®
or BOTOX® Cosmetic should be discontinued.
Tell your doctor about all your muscle or nerve
conditions, such as ALS or Lou
Gehrig's disease, myasthenia gravis, or Lambert-Eaton
syndrome, as you may be at increased risk of serious side effects
including difficulty swallowing and difficulty breathing from
typical doses of BOTOX® or BOTOX® Cosmetic.
Tell your doctor if you have any breathing-related
problems. Your doctor may monitor you for breathing problems
during treatment with BOTOX® for spasticity or for detrusor
overactivity associated with a neurologic condition. The risk of
developing lung disease in patients with reduced lung function is
increased in patients receiving BOTOX®.
Cornea problems have been reported. Cornea (surface of
the eye) problems have been reported in some people receiving
BOTOX® for their Blepharospasm, especially in people with certain
nerve disorders. BOTOX® may cause the eyelids to blink less, which
could lead to the surface of the eye being exposed to air more than
is usual. Tell your doctor if you experience any problems with your
eyes while receiving BOTOX®. Your doctor may treat your eyes with
drops, ointments, contact lenses, or with an eye patch.
Bleeding behind the eye has been reported. Bleeding
behind the eyeball has been reported in some people receiving
BOTOX® for their Strabismus. Tell your doctor if you notice any new
visual problems while receiving BOTOX®.
Bronchitis and upper respiratory tract infections (common
colds) have been reported. Bronchitis was reported more
frequently in adults receiving BOTOX® for upper limb spasticity.
Upper respiratory infections were also reported more frequently in
adults with prior breathing-related problems with spasticity. In
pediatric patients treated with BOTOX® for upper limb spasticity,
upper respiratory tract infections were reported more frequently.
In pediatric patients treated with BOTOX® for lower limb
spasticity, upper respiratory tract infections were not reported
more frequently than placebo.
Autonomic dysreflexia in patients treated for overactive
bladder due to neurologic disease. Autonomic dysreflexia
associated with intradetrusor injections of BOTOX® could occur in
patients treated for detrusor overactivity associated with a
neurologic condition and may require prompt medical therapy. In
clinical trials, the incidence of autonomic dysreflexia was greater
in patients treated with BOTOX® 200 Units compared with placebo
(1.5% versus 0.4%, respectively).
Tell your doctor about all your medical conditions, including
if you: have or have had bleeding problems; have plans to have
surgery; had surgery on your face; weakness of forehead muscles;
trouble raising your eyebrows; drooping eyelids; any other abnormal
facial change; have symptoms of a urinary tract infection (UTI) and
are being treated for urinary incontinence (symptoms of a urinary
tract infection may include pain or burning with urination,
frequent urination, or fever); have problems emptying your bladder
on your own and are being treated for urinary incontinence; are
pregnant or plan to become pregnant (it is not known if BOTOX® or
BOTOX® Cosmetic can harm your unborn baby); are breastfeeding or
plan to (it is not known if BOTOX® or BOTOX® Cosmetic passes into
breast milk).
Tell your doctor about all the medicines you take,
including prescription and over-the-counter medicines, vitamins,
and herbal supplements. Using BOTOX® or BOTOX® Cosmetic with
certain other medicines may cause serious side effects. Do not
start any new medicines until you have told your doctor that
you have received BOTOX® or BOTOX®
Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin
product in the last 4 months; have received injections of botulinum
toxin such as Myobloc®, Dysport®, or Xeomin®
in the past (tell your doctor exactly which product you received);
have recently received an antibiotic by injection; take muscle
relaxants; take an allergy or cold medicine; take a sleep medicine;
take aspirin-like products or blood thinners.
Other side effects of BOTOX® and BOTOX®
Cosmetic include: dry mouth, discomfort or pain at the
injection site, tiredness, headache, neck pain, eye problems:
double vision, blurred vision, decreased eyesight, drooping
eyelids, swelling of your eyelids, dry eyes; drooping eyebrows; and
upper respiratory tract infection. In people being treated for
urinary incontinence other side effects include: urinary tract
infection, painful urination, and/or inability to empty your
bladder on your own. If you have difficulty fully emptying your
bladder after receiving BOTOX®, you may need to use disposable
self-catheters to empty your bladder up to a few times each day
until your bladder is able to start emptying again.
For more information refer to the Medication Guide or talk with
your doctor.
You are encouraged to report negative side effects of
prescription drugs to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.
Please see BOTOX® full Product
Information, including Boxed Warning and
Medication Guide.
Please see BOTOX® Cosmetic full Product
Information, including Boxed Warning and
Medication Guide.
About Allergan Aesthetics
Allergan Aesthetics,
an AbbVie company, develops, manufactures, and markets a portfolio
of leading aesthetics brands and products. Their aesthetics
portfolio includes facial injectables, body contouring, plastics,
skin care, and more. Their goal is to consistently provide
customers worldwide with innovation, education, exceptional
service, and a commitment to excellence, all with a personal
touch.
www.AllerganAesthetics.com
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram, YouTube and
LinkedIn.
References
- Data on File, Allergan; Situational Analysis, June 2020.
- BOTOX® Prescribing Information, 2020.
- Data on File, Allergan; Peer-Reviewed Articles, 2018.
- BOTOX® Prescribing Information, 2020.
View original
content:http://www.prnewswire.com/news-releases/allergan-aesthetics-celebrates-second-annual-botox-cosmetic-onabotulinumtoxina-day-301173148.html
SOURCE AbbVie